Burrows Francis

Reporting owner on Forms 3, 4 and 5, CIK 2051119.

Burrows Francis reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-25.

Issuers

Issuer	Roles in the latest filing	Filings	Last filed
Kura Oncology, Inc. CIK 1422143	officer (Chief Scientific Officer)	1	2026-09-25

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

Security	Date	Code	Shares	Price	Owned after	Filing
Kura Oncology, Inc. Common Stock	2026-09-24	M exercised	+30,000	$6.15	63,053	Form 4
Kura Oncology, Inc. Common Stock	2026-09-24	S sold	-20,726	$10.8325	42,327	Form 4
Kura Oncology, Inc. Stock Option (Right to Buy), derivative	2026-09-24	M exercised	-30,000	$0	0	Form 4

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

Filing	Subject	Filed	Accepted	Ingested
Form 4 0001193125-26-402815	Kura Oncology, Inc.	2026-09-25	2026-09-25 20:05:07 UTC	2026-10-06 09:56:51 UTC